TY - JOUR
T1 - Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
AU - Aschauer, Constantin
AU - Jelencsics, Kira
AU - Hu, Karin
AU - Heinzel, Andreas
AU - Gregorich, Mariella Gloria
AU - Vetter, Julia
AU - Schaller, Susanne
AU - Winkler, Stephan M.
AU - Weinberger, Johannes
AU - Pimenov, Lisabeth
AU - Gualdoni, Guido A.
AU - Eder, Michael
AU - Kainz, Alexander
AU - Troescher, Anna Regina
AU - Regele, Heinz
AU - Reindl-Schwaighofer, Roman
AU - Wekerle, Thomas
AU - Huppa, Johannes Bernhard
AU - Sykes, Megan
AU - Oberbauer, Rainer
N1 - Funding Information:
We acknowledge the help of the staff members of the transplant department of the Medical University of Vienna in obtaining the biospecimen and the Austrian Science Fund (grant number: P 26936-B27).
Funding Information:
The study was founded by a peer-reviewed funding by the Scientific Funds of the Austrian National Bank-OeNb project number 17289 (https://www.oenb.at). The funding body had no influence on the design, collection, analysis, and interpretation of data and writing the manuscript.
Publisher Copyright:
© Copyright © 2021 Aschauer, Jelencsics, Hu, Heinzel, Gregorich, Vetter, Schaller, Winkler, Weinberger, Pimenov, Gualdoni, Eder, Kainz, Troescher, Regele, Reindl-Schwaighofer, Wekerle, Huppa, Sykes and Oberbauer.
PY - 2021/10/14
Y1 - 2021/10/14
N2 - Background: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. Methods/Design: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. Results: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4
+), p = 0.52 (CD8
+)]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. Conclusion: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. Trial Registration: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224).
AB - Background: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. Methods/Design: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. Results: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4
+), p = 0.52 (CD8
+)]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. Conclusion: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. Trial Registration: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224).
KW - T-cell receptor
KW - alloreactivity
KW - kidney transplant
KW - network analysis
KW - next generation sequencing
KW - rejection
KW - Allografts/immunology
KW - Receptors, Antigen, T-Cell/genetics
KW - T-Lymphocytes/immunology
KW - Humans
KW - Graft Rejection/immunology
KW - Male
KW - Kidney Transplantation
KW - Female
KW - Tissue Donors
UR - http://www.scopus.com/inward/record.url?scp=85118302625&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.750005
DO - 10.3389/fimmu.2021.750005
M3 - Article
C2 - 34721420
SN - 1664-3224
VL - 12
SP - 750005
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 750005
ER -